Skip to main content
. Author manuscript; available in PMC: 2014 Mar 1.
Published in final edited form as: Transl Res. 2012 Sep 27;161(3):145–155. doi: 10.1016/j.trsl.2012.08.006

Table 1.

Baseline Patient Characteristics

Characteristics Placebo Pioglitazone
n 5 5
Age (yr) 60 (6) 52 (10)
Gender: Male:Female (%) 40:60 20:80
Postmenopausal Females % 66% 25%
Weight (kg) 80 (17) 92 (27)
BMI 30 (8) 33 (10)
Oral antidiabetic agents:
 Metformin only 40% 40%
 Sulfonylurea only 20% 0
 Metformin + Sulfonylurea 40% 60%
 Statin use (%) 80% 60%
Baseline HbA1c 7.6%(0.5) 7.6%(0.4)
Lumbar Spine BMD (g/cm2) 1.21 (0.12) 1.25(0.28)
Femoral Neck BMD (g/cm2) 1.04 (0.1) 1.02 (0.17)

Values are presented as the average +/− SD.